Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagnostic Products Corporation (DPC) was a global leader in the development and manufacture of automated immunodiagnostic systems and reagents. Founded in 1971, the company specialized in in-vitro diagnostic (IVD) testing, providing a vast menu of assays for conditions ranging from thyroid disorders and allergies to oncology and infectious diseases. Its flagship IMMULITE platform became a gold standard for automated immunoassay testing in clinical laboratories worldwide. In 2006, DPC was acquired by Siemens for approximately $1.86 billion, serving as a foundational acquisition for the creation of Siemens Healthineers' diagnostics division. The company's legacy technologies continue to underpin a significant portion of the modern Siemens immunoassay portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diagnostic Products.